P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO. 2022; 6(3): 232-240 | DOI: 10.14744/ejmo.2022.78475

The Involvement of Interleukin-10 Promoter Genetic Polymorphism in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma from North Africa

Khalid Moumad1, Wafa Khaali2, Abdellatif Benider3, Wided Ben Ayoub4, Mokhtar Hamdi Cherif5, Kada Boualga6, Meriem Khyatti1
1Oncovirology Laboratory, Institut Pasteur du Maroc, 20360 Casablanca, Morocco, 2Department of Biology, Faculty of Sciences, Abdelmalek Essaadi University, 93030 Tetouan, Morocco, 3Centre Mohamed VI de la Lutte contre le Cancer, 20360 Casablanca, Morocco, 4Association Tunisienne de Lutte Contre le Cancer, 10006 Tunis, Tunisia, 5Service d'épidémiologie, CHU de Sétif, 1900 Sétif, Algeria, 6Service de Radiothérapie Oncologique, Centre Anti-Cancer de Blida, 09000 Blida, Algeria,

Objectives: Interleukin-10 (IL10) is a pro-inflammatory cytokine that plays a pivotal role in inflammatory diseases as well as in the pathogenesis of diverse tumors, including nasopharyngeal carcinoma (NPC). The present study was designed to evaluate the importance of the functional promoter polymorphisms of IL10 (-1082 A>G and -592 A>C) in the development of NPC. Methods: A total of 384 patients with NPC were recruited into this study, together with 375 matched control subjects. Polymorphisms within the promoter region of IL10 gene were analysed using PCR-RFLP method. Results: We report a lack of association between IL10 polymorphisms and NPC in the overall population (P>0.05). However, the 1082 A>G polymorphism was significantly associated with the susceptibility to NPC among young patients (age ?30 years). The GG genotype was found to be associated with a significantly higher risk of NPC as compared with the AA genotype among young patients (OR=2.534; 95% CI, 1.189–5.398, P=0.016). Conclusion: The results of the present study indicate an association between IL10 -1082 GG genotype and NPC among young North African subjects. This difference in IL10 polymorphism association with different ages at the onset of NPC suggests that the younger and older onset patients are genetically different and may involve different mechanisms. Keywords: Nasopharyngeal Carcinoma, IL10, North African population


Cite This Article

Moumad K, Khaali W, Benider A, Ayoub W, Cherif M, Boualga K, et al. The Involvement of Interleukin-10 Promoter Genetic Polymorphism in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma from North Africa. EJMO. 2022; 6(3): 232-240

Corresponding Author: Meriem Khyatti

Full Text PDF PDF Download
EJMO & EJMO